D-ENANTIOMERIC PEPTIDES FOR ANTI-INFLAMMATORY TREATMENT OF AMYOTROPIC LATERAL SCLEROSIS (ALS) AND OTHER DISEASES DRIVEN BY NEURO-INFLAMMATION

摘要

The present invention relates to a polymer comprising at least one monomer, the at least one monomer comprising a peptide having an amino acid sequence selected from the group consisting of SEQ ID NO: 1 or homologs with an identity of at least 80% thereof, and a pharmaceutical composition comprising such a peptide for use in the treatment of amyotrophic lateral sclerosis (ALS).